Management of New-Onset Hypotension on Metoprolol

Dosing Strategy

The American College of Cardiology recommends reducing the dose to metoprolol ER 25mg once daily rather than maintaining twice-daily dosing, as this preserves beta-blockade benefits while minimizing hypotensive effects through lower total daily exposure 1
By switching to 25mg once daily, patients achieve lower total daily dose, reducing hypotensive burden, and maintained steady-state beta-blockade throughout the 24-hour period with ER formulation 1
Preservation of cardiovascular benefits is crucial, as some beta-blocker is superior to none, with complete discontinuation increasing mortality risk 2.7-fold 1

Before dose adjustment, check for contraindications requiring complete cessation, including systolic blood pressure <100 mmHg with symptoms of hypoperfusion, heart rate <50 bpm with symptoms, and signs of decompensated heart failure 1, 2
Monitor blood pressure and heart rate at each visit within 1-2 weeks of switching to 25mg once daily, targeting systolic BP >100 mmHg and heart rate 50-60 bpm 1
Watch specifically for worsening of underlying condition, such as angina, heart failure symptoms, and arrhythmias 1

Abrupt discontinuation of metoprolol should be avoided, as it causes severe exacerbation of angina, myocardial infarction, and ventricular arrhythmias, with documented 50% mortality in one study and 2.7-fold increased risk of 1-year mortality compared to continuous use 1
If hypotension persists despite dose reduction to 25mg daily and beta-blockade remains clinically indicated, consider switching to a different beta-blocker with less hypotensive effect or consulting cardiology for alternative rate/rhythm control strategies 1